These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

545 related items for PubMed ID: 29241647

  • 1. Safety of currently licensed hepatitis B surface antigen vaccines in the United States, Vaccine Adverse Event Reporting System (VAERS), 2005-2015.
    Haber P, Moro PL, Ng C, Lewis PW, Hibbs B, Schillie SF, Nelson NP, Li R, Stewart B, Cano MV.
    Vaccine; 2018 Jan 25; 36(4):559-564. PubMed ID: 29241647
    [Abstract] [Full Text] [Related]

  • 2. Comparative safety of two recombinant hepatitis B vaccines in children: data from the Vaccine Adverse Event Reporting System (VAERS) and Vaccine Safety Datalink (VSD).
    Niu MT, Rhodes P, Salive M, Lively T, Davis DM, Black S, Shinefield H, Chen RT, Ellenberg SS.
    J Clin Epidemiol; 1998 Jun 25; 51(6):503-10. PubMed ID: 9635999
    [Abstract] [Full Text] [Related]

  • 3. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.
    Zhou W, Pool V, Iskander JK, English-Bullard R, Ball R, Wise RP, Haber P, Pless RP, Mootrey G, Ellenberg SS, Braun MM, Chen RT.
    MMWR Surveill Summ; 2003 Jan 24; 52(1):1-24. PubMed ID: 12825543
    [Abstract] [Full Text] [Related]

  • 4. Assessing the safety of hepatitis B vaccination during pregnancy in the Vaccine Adverse Event Reporting System (VAERS), 1990-2016.
    Moro PL, Zheteyeva Y, Barash F, Lewis P, Cano M.
    Vaccine; 2018 Jan 02; 36(1):50-54. PubMed ID: 29174107
    [Abstract] [Full Text] [Related]

  • 5. Post-licensure safety surveillance of zoster vaccine live (Zostavax®) in the United States, Vaccine Adverse Event Reporting System (VAERS), 2006-2015.
    Miller ER, Lewis P, Shimabukuro TT, Su J, Moro P, Woo EJ, Jankosky C, Cano M.
    Hum Vaccin Immunother; 2018 Jan 02; 14(8):1963-1969. PubMed ID: 29580194
    [Abstract] [Full Text] [Related]

  • 6. Post-licensure surveillance of trivalent adjuvanted influenza vaccine (aIIV3; Fluad), Vaccine Adverse Event Reporting System (VAERS), United States, July 2016-June 2018.
    Haber P, Moro PL, Ng C, Dores GM, Lewis P, Cano M.
    Vaccine; 2019 Mar 07; 37(11):1516-1520. PubMed ID: 30739795
    [Abstract] [Full Text] [Related]

  • 7. Post-licensure surveillance of 13-valent pneumococcal conjugate vaccine (PCV13) in adults aged ⩾19years old in the United States, Vaccine Adverse Event Reporting System (VAERS), June 1, 2012-December 31, 2015.
    Haber P, Arana J, Pilishvili T, Lewis P, Moro PL, Cano M.
    Vaccine; 2016 Dec 07; 34(50):6330-6334. PubMed ID: 27836437
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Post-licensure surveillance of trivalent live attenuated influenza vaccine in adults, United States, Vaccine Adverse Event Reporting System (VAERS), July 2005-June 2013.
    Haber P, Moro PL, McNeil MM, Lewis P, Woo EJ, Hughes H, Shimabukuro TT.
    Vaccine; 2014 Nov 12; 32(48):6499-504. PubMed ID: 25258101
    [Abstract] [Full Text] [Related]

  • 10. Post-licensure safety monitoring of quadrivalent human papillomavirus vaccine in the Vaccine Adverse Event Reporting System (VAERS), 2009-2015.
    Arana JE, Harrington T, Cano M, Lewis P, Mba-Jonas A, Rongxia L, Stewart B, Markowitz LE, Shimabukuro TT.
    Vaccine; 2018 Mar 20; 36(13):1781-1788. PubMed ID: 29477308
    [Abstract] [Full Text] [Related]

  • 11. Adverse events following quadrivalent meningococcal CRM-conjugate vaccine (Menveo®) reported to the Vaccine Adverse Event Reporting system (VAERS), 2010-2015.
    Myers TR, McNeil MM, Ng CS, Li R, Lewis PW, Cano MV.
    Vaccine; 2017 Mar 27; 35(14):1758-1763. PubMed ID: 28262331
    [Abstract] [Full Text] [Related]

  • 12. Preparation for global introduction of inactivated poliovirus vaccine: safety evidence from the US Vaccine Adverse Event Reporting System, 2000-12.
    Iqbal S, Shi J, Seib K, Lewis P, Moro PL, Woo EJ, Shimabukuro T, Orenstein WA.
    Lancet Infect Dis; 2015 Oct 27; 15(10):1175-1182. PubMed ID: 26289956
    [Abstract] [Full Text] [Related]

  • 13. Post-licensure surveillance of quadrivalent live attenuated influenza vaccine United States, Vaccine Adverse Event Reporting System (VAERS), July 2013-June 2014.
    Haber P, Moro PL, Cano M, Lewis P, Stewart B, Shimabukuro TT.
    Vaccine; 2015 Apr 15; 33(16):1987-92. PubMed ID: 25678241
    [Abstract] [Full Text] [Related]

  • 14. Loss of confidence in vaccines following media reports of infant deaths after hepatitis B vaccination in China.
    Yu W, Liu D, Zheng J, Liu Y, An Z, Rodewald L, Zhang G, Su Q, Li K, Xu D, Wang F, Yuan P, Xia W, Ning G, Zheng H, Chu Y, Cui J, Duan M, Hao L, Zhou Y, Wu Z, Zhang X, Cui F, Li L, Wang H.
    Int J Epidemiol; 2016 Apr 15; 45(2):441-9. PubMed ID: 27174834
    [Abstract] [Full Text] [Related]

  • 15. Adverse events after Fluzone ® Intradermal vaccine reported to the Vaccine Adverse Event Reporting System (VAERS), 2011-2013.
    Moro PL, Harrington T, Shimabukuro T, Cano M, Museru OI, Menschik D, Broder K.
    Vaccine; 2013 Oct 09; 31(43):4984-7. PubMed ID: 23994022
    [Abstract] [Full Text] [Related]

  • 16. Is there any harm in administering extra-doses of vaccine to a person? Excess doses of vaccine reported to the Vaccine Adverse Event Reporting System (VAERS), 2007-2017.
    Moro PL, Arana J, Marquez PL, Ng C, Barash F, Hibbs BF, Cano M.
    Vaccine; 2019 Jun 19; 37(28):3730-3734. PubMed ID: 31155414
    [Abstract] [Full Text] [Related]

  • 17. Post-licensure surveillance of quadrivalent inactivated influenza (IIV4) vaccine in the United States, Vaccine Adverse Event Reporting System (VAERS), July 1, 2013-May 31, 2015.
    Haber P, Moro PL, Lewis P, Woo EJ, Jankosky C, Cano M.
    Vaccine; 2016 May 11; 34(22):2507-12. PubMed ID: 27015735
    [Abstract] [Full Text] [Related]

  • 18. Surveillance of adverse events after the first trivalent inactivated influenza vaccine produced in mammalian cell culture (Flucelvax(®)) reported to the Vaccine Adverse Event Reporting System (VAERS), United States, 2013-2015.
    Moro PL, Winiecki S, Lewis P, Shimabukuro TT, Cano M.
    Vaccine; 2015 Nov 27; 33(48):6684-8. PubMed ID: 26518405
    [Abstract] [Full Text] [Related]

  • 19. Post-Licensure Surveillance of Trivalent Live-Attenuated Influenza Vaccine in Children Aged 2-18 Years, Vaccine Adverse Event Reporting System, United States, July 2005-June 2012.
    Haber P, Moro PL, Cano M, Vellozzi C, Lewis P, Woo EJ, Broder K.
    J Pediatric Infect Dis Soc; 2015 Sep 27; 4(3):205-13. PubMed ID: 26407428
    [Abstract] [Full Text] [Related]

  • 20. Neonatal deaths after hepatitis B vaccine: the vaccine adverse event reporting system, 1991-1998.
    Niu MT, Salive ME, Ellenberg SS.
    Arch Pediatr Adolesc Med; 1999 Dec 27; 153(12):1279-82. PubMed ID: 10591306
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.